Mesenchymal stem cells from development to postnatal joint homeostasis, aging, and disease

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 90, Issue 4, 2010, Pages 257-271

  De Bari, Cosimo ^a   Kurth, Tobias B ^a   Augello, Andrea ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Aging; Arthritis; Joint development; Mesenchymal stem cells; Regenerative medicine

Indexed keywords

GROWTH FACTOR;

AGING; ARTHROPATHY; ARTICULAR CARTILAGE; BONE; CELL DIFFERENTIATION; CELL MATURATION; CELL THERAPY; CULTURE TECHNIQUE; EMBRYO DEVELOPMENT; HOMEOSTASIS; HUMAN; INJURY; JOINT INJURY; MESENCHYMAL STEM CELL; MORPHOGENESIS; MORPHOLOGICAL TRAIT; NONHUMAN; ONTOGENY; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RHEUMATOID ARTHRITIS; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL NICHE; SYNOVIOCYTE; SYNOVIUM; TISSUE REGENERATION;

AGING; CARTILAGE; CELL DIFFERENTIATION; HOMEOSTASIS; HUMANS; JOINTS; MESENCHYMAL STEM CELLS; MUSCULOSKELETAL SYSTEM; OSTEOARTHRITIS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 78650490587     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20189     Document Type: Review

References (166)

1. Amizuka N, Warshawsky H, Henderson JE, et al. 1994. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126: 1611-1623.
2. Archer CW, Morrison H, Pitsillides AA. 1994. Cellular aspects of the development of diarthrodial joints and articular cartilage. J Anat 184 (Pt 3): 447-456.
3. Augello A, De Bari C. 2010. The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther 21: 1226-1238.
4. Augello A, Kurth TB, De Bari C. 2010. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. ECM 20: 121-133.
5. Banfi A, Muraglia A, Dozin B, et al. 2000. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28: 707-715.
6. Banfi A, Bianchi G, Notaro R, et al. 2002. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 8: 901-910.
7. Barry F, Boynton RE, Liu B, Murphy JM. 2001. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268: 189-200.
8. Baxter MA, Wynn RF, Jowitt SN, et al. 2004. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22: 675-682.
9. Bertram H, Mayer H, Schliephake H. 2005. Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone. Clin Oral Implants Res 16: 524-531.
10. Bork S, Pfister S, Witt H, et al. 2010. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63.
11. Brittberg M, Lindahl A, Nilsson A, et al. 1994. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895.
12. Bruder SP, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278-294.
13. Brunet LJ, McMahon JA, McMahon AP, Harland RM. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455-1457.
14. Buckwalter JA, Saltzman C, Brown T. 2004. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res(427 Suppl): S6-S15.
15. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9: 641-650.
16. Caplan AI, Bruder SP. 2001. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7: 259-264.
17. Castro-Malaspina H, Gay RE, Resnick G, et al. 1980. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56: 289-301.
18. Covas DT, Panepucci RA, Fontes AM, et al. 2008. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 36: 642-654.
19. Craig FM, Bayliss MT, Bentley G, Archer CW. 1990. A role for hyaluronan in joint development. J Anat 171: 17-23.
20. Crisan M, Yap S, Casteilla L, et al. 2008. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
21. da Silva Meirelles L, Chagastelles PC, Nardi NB. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213.
22. da Silva Meirelles L, Caplan AI, Nardi NB. 2008. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299.
23. De Bari C. 2007. Stem cell therapy: an exciting prospect for rheumatology. Rheumatol Pract 5: 6-8.
24. De Bari C, Dell'Accio F. 2007. Mesenchymal stem cells in rheumatology: a regenerative approach to joint repair. Clin Sci (Lond) 113: 339-348.
25. De Bari C, Dell'Accio F. 2008. Cell therapy: a challenge in modern medicine. Biomed Mater Eng 18: S11-S17.
26. De Bari C, Dell'Accio F, Luyten FP. 2001a. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 44: 85-95.
27. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. 2001b. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942.
28. De Bari C, Dell'Accio F, Vandenabeele F, et al. 2003. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160: 909-918.
29. De Bari C, Dell'Accio F, Luyten FP. 2004. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 50: 142-150.
30. De Bari C, Dell'Accio F, Vanlauwe J, et al. 2006a. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 54: 1209-1221.
31. De Bari C, Pitzalis C, Dell'Accio F. 2006b. Reparative medicine: from tissue engineering to joint surface regeneration. Regen Med 1: 59-69.
32. De Bari C, Pringle S, Pitzalis C, Dell'Accio F. 2006c. The stem cell niche: a new target in medicine. Curr Opin Orthop 17: 398-404.
33. De Bari C, Dell'Accio F, Karystinou A, et al. 2008. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58: 240-250.
34. Dell'Accio F, De Bari C, Luyten FP. 1999. Molecular basis of joint development. Jpn J Rheumatol 9: 17-29.
35. Dell'Accio F, De Bari C, Luyten FP. 2001. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum 44: 1608-1619.
36. Denker AE, Haas AR, Nicoll SB, Tuan RS. 1999. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 64: 67-76.
37. Dhordain P, Dewitte F, Desbiens X, et al. 1995. Mesodermal expression of the chicken erg gene associated with precartilaginous condensation and cartilage differentiation. Mech Dev 50: 17-28.
38. Diarra D, Stolina M, Polzer K, Zwerina J, et al. 2007. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156-163.
39. D'Ippolito G, Schiller PC, Ricordi C, et al. 1999. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14: 1115-1122.
40. Dominici M, Le Blanc K, Mueller I, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
41. Dowthwaite GP, Bishop JC, Redman SN, et al. 2004. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 117: 889-897.
42. Durand C, Robin C, andDzierzak E. 2006. Mesenchymal lineage potentials of aorta-gonad-mesonephros stromal clones. Haematologica 91: 1172-1179.
43. Edwards JC, Wilkinson LS, Jones HM, et al. 1994. The formation of human synovial joint cavities: a possible role for hyaluronan and CD44 in altered interzone cohesion. J Anat 185 (Pt 2): 355-367.
44. Egrise D, Martin D, Vienne A, et al. 1992. The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone 13: 355-361.
45. Eltawil NM, De Bari C, Achan P, et al. 2009. A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury. Osteoarthr Cartilage 17: 695-704.
46. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, et al. 2000. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275: 8695-8702.
47. Fickert S, Fiedler J, Brenner RE. 2004. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 6: R422-R432.
48. Fickert S, Schroter-Bobsin U, Gross AF, et al. 2010. Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab. Epub ahead of print (DOI: 10.1007/s00774-010-0215-y).
49. Fiorina P, Jurewicz M, Augello A, et al. 2009. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183: 993-1004.
50. Francis-West PH, Richardson MK, Bell E, et al. 1996. The effect of overexpression of BMPs and GDF-5 on the development of chick limb skeletal elements. Ann NY Acad Sci 785: 254-255.
51. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3: 393-403.
52. Friedenstein AJ, Gorskaja JF, Kulagina NN. 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274.
53. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. 1987. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20: 263-272.
54. Fuchs E, Tumbar T, Guasch G. 2004. Socializing with the neighbors: stem cells and their niche. Cell 116: 769-778.
55. Greco V, Guo S. 2010. Compartmentalized organization: a common and required feature of stem cell niches? Development 137: 1586-1594.
56. Guillot PV, Gotherstrom C, Chan J, et al. 2007. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25: 646-654.
57. Guillot PV, De Bari C, Dell'Accio F, et al. 2008. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 76: 946-957.
58. Guo X, Day TF, Jiang X, et al. 2004. Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev 18: 2404-2417.
59. Guo Z, Li H, Li X, et al. 2006. In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 24: 992-1000.
60. Hartmann C, Tabin CJ. 2001. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104: 341-351.
61. Hogan BL. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10: 1580-1594.
62. Horner A, Kemp P, Summers C, et al. 1998. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 23: 95-102.
63. Im GI, Jung NH, Tae SK. 2006. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 12: 527-536.
64. Iwamoto M, Higuchi Y, Enomoto-Iwamoto M, et al. 2001. The role of ERG (ets related gene) in cartilage development. Osteoarthr Cartil 9 (Suppl A): S41-S47.
65. Iwamoto M, Higuchi Y, Koyama E, et al. 2000. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J Cell Biol 150: 27-40.
66. Iwamoto M, Koyama E, Enomoto-Iwamoto M, Pacifici M. 2005. The balancing act of transcription factors C-1-1 and Runx2 in articular cartilage development. Biochem Biophys Res Commun 328: 777-782.
67. Iwamoto M, Tamamura Y, Koyama E, et al. 2007. Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. Dev Biol 305: 40-51.
68. Johnstone B, Hering TM, Caplan AI, et al. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238: 265-272.
69. Jones EA, English A, Henshaw K, et al. 2004. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50: 817-827.
70. Justesen J, Stenderup K, Eriksen EF, Kassem M. 2002. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 71: 36-44.
71. Karaplis AC, Luz A, Glowacki J, et al. 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8: 277-289.
72. Karystinou A, Dell'Accio F, Kurth T.B, et al. 2009. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology (Oxford) 48: 1057-1064.
73. Kimura S, Shiota K. 1996. Sequential changes of programmed cell death in developing fetal mouse limbs and its possible roles in limb morphogenesis. J Morphol 229: 337-346.
74. Kingsley DM. 1994. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet 10: 16-21.
75. Knutsen G, Engebretsen L, Ludvigsen TC, et al. 2004. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am A 86: 455-464.
76. Komori T, Yagi H, Nomura S, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
77. Kon E, Muraglia A, Corsi A, et al. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49: 328-337.
78. Koshino T, Wada S, Ara Y, Saito T. 2003. Regeneration of degenerated articular cartilage after high tibial valgus osteotomy for medial compartmental osteoarthritis of the knee. Knee 10: 229-236.
79. Koyama E, Shibukawa Y, Nagayama M, et al. 2008. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev Biol 316: 62-73.
80. Kurth TB, Dell' Accio F, Crouch V, et al. Functional Mesenchymal Stem Cell Niches In The Adult Knee Joint Synovium In Vivo. Arthritis Rheum (in press).
81. Lanske B, Karaplis AC, Lee K, et al. 1996. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273: 663-666.
82. Lee K, Lanske B, Karaplis AC, et al. 1996. Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137: 5109-5118.
83. Lee CH, Cook JL, Mendelson A, et al. 2010. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 376: 440-448.
84. Lelkes G. 1958. Experiments in vitro on the role of movement in the development of joints. J Embryol Exp Morphol 6: 183-186.
85. Leskela HV, Risteli J, Niskanen S, et al. 2003. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311: 1008-1013.
86. Lories RJ, Daans M, Derese I, et al. 2006. Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum 54: 1736-1746.
87. Lories RJ, Derese I, Luyten FP. 2005. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 115: 1571-1579.
88. Macias D, Ganan Y, Sampath TK, et al. 1997. Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development. Development 124: 1109-1117.
89. Mackay AM, Beck SC, Murphy JM, et al. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4: 415-428.
90. Majors AK, Boehm CA, Nitto H, et al. 1997. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15: 546-557.
91. Majumdar MK, Wang E, Morris EA. 2001. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 189: 275-284.
92. Marcacci M, Kon E, Zaffagnini S, et al. 1999. Reconstruction of extensive long-bone defects in sheep using porous hydroxyapatite sponges. Calcif Tissue Int 64: 83-90.
93. Meirelles Lda S, Nardi NB. 2003. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123: 702-711.
94. Mendes SC, Tibbe JM, Veenhof M, et al. 2002. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8: 911-920.
95. Mendes SC, Robin C, Dzierzak E. 2005. Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny. Development 132: 1127-1136.
96. Mets T, Verdonk G. 1981. In vitro aging of human bone marrow derived stromal cells. Mech Ageing Dev 16: 81-89.
97. Mikic B, Johnson TL, Chhabra AB, et al. 2000. Differential effects of embryonic immobilization on the development of fibrocartilaginous skeletal elements. J Rehabil Res Dev 37: 127-133.
98. Mitrovic D. 1978. Development of the diarthrodial joints in the rat embryo. Am J Anat 151: 475-485.
99. Mitrovic D. 1982. Development of the articular cavity in paralyzed chick embryos and in chick embryo limb buds cultured on chorioallantoic membranes. Acta Anat (Basel) 113: 313-324.
100. Mitsiadis TA, Barrandon O, Rochat A, et al. 2007. Stem cell niches in mammals. Exp Cell Res 313: 3377-3385.
101. Morikawa S, Mabuchi Y, Niibe K, et al. 2009. Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun 379: 1114-1119.
102. Muraglia A, Martin I, Cancedda R, Quarto R. 1998. A nude mouse model for human bone formation in unloaded conditions. Bone 22: 131S-134S.
103. Murphy JM, Dixon K, Beck S, et al. 2002. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 46: 704-713.
104. Muschler GF, Nitto H, Boehm CA, Easley KA. 2001. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19: 117-125.
105. Nagoshi N, Shibata S, Kubota Y, et al. 2008. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2: 392-403.
106. Nakahara H, Dennis JE, Bruder SP, et al. 1991. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 195: 492-503.
107. Nakamura T, Aikawa T, Iwamoto-Enomoto M, et al. 1997. Induction of osteogenic differentiation by hedgehog proteins. Biochem Biophys Res Commun 237: 465-469.
108. Nalin AM, Greenlee TKJr, Sandell LJ. 1995. Collagen gene expression during development of avian synovial joints: transient expression of types II and XI collagen genes in the joint capsule. Dev Dyn 203: 352-362.
109. Niedermaier M, Schwabe GC, Fees S, et al. 2005. An inversion involving the mouse Shh locus results in brachydactyly through dysregulation of Shh expression. J Clin Invest 115: 900-909.
110. Nishida S, Endo N, Yamagiwa H, et al. 1999. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 17: 171-177.
111. Noth U, Osyczka AM, Tuli R, et al. 2002. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20: 1060-1069.
112. O'Driscoll SW, Saris DB, Ito Y, Fitzimmons JS. 2001. The chondrogenic potential of periosteum decreases with age. J Orthop Res 19: 95-103.
113. Ohgushi H, Okumura M. 1990. Osteogenic capacity of rat and human marrow cells in porous ceramics. Experiments in athymic (nude) mice. Acta Orthop Scand 61: 431-434.
114. Oreffo RO, Bennett A, Carr AJ, Triffitt JT. 1998a. Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. Scand J Rheumatol 27: 415-424.
115. Oreffo RO, Bord S, Triffitt JT. 1998b. Skeletal progenitor cells and ageing human populations. Clin Sci (Lond) 94: 549-555.
116. Pacifici M, Koyama E, Iwamoto M. 2005. Mechanisms of synovial joint and articular cartilage formation: recent advances, but many lingering mysteries. Birth Defects Res C Embryo Today 75: 237-248.
117. Peister A, Mellad JA, Larson BL, et al. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103: 1662-1668.
118. Pelttari K, Winter A, Steck E, et al. 2006. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54: 3254-3266.
119. Peterson L, Vasiliadis HS, Brittberg M, Lindahl A. 2010. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 38: 1117-1124.
120. Phinney DG, Kopen G, Righter W, et al. 1999. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436.
121. Pitsillides AA, Archer CW, Prehm P, et al. 1995. Alterations in hyaluronan synthesis during developing joint cavitation. J Histochem Cytochem 43: 263-273.
122. Pittenger MF, Mackay AM, Beck SC. 1999a. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
123. Pittenger MF, Mackay AM, Beck SC, et al. 1999b. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
124. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
125. Qiu YS, Shahgaldi BF, Revell WJ, Heatley FW. 2003. Observations of subchondral plate advancement during osteochondral repair: a histomorphometric and mechanical study in the rabbit femoral condyle. Osteoarthr Cartil 11: 810-820.
126. Quarto R, Thomas D, Liang CT. 1995. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 56: 123-129.
127. Quarto R, Mastrogiacomo M, Cancedda R, et al. 2001. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344: 385-386.
128. Rountree RB, Schoor M, Chen H, et al. 2004. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol 2: e355.
129. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. 2005. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52: 2521-2529.
130. Scadden DT. 2006. The stem-cell niche as an entity of action. Nature 441: 1075-1079.
131. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB. 2003. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 48: 3442-3451.
132. Scharstuhl A, Schewe B, Benz K, et al. 2007. Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells 25: 3244-3251.
133. Scotti C, Tonnarelli B, Papadimitropoulos A, et al. 2010. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci USA 107: 7251-7256.
134. Sekiya I, Colter DC, Prockop DJ. 2001. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun 284: 411-418.
135. Serra R, Johnson M, Filvaroff EH, et al. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139: 541-552.
136. Shimo T, Gentili C, Iwamoto M, et al. 2004. Indian hedgehog and syndecans-3 coregulate chondrocyte proliferation and function during chick limb skeletogenesis. Dev Dyn 229: 607-617.
137. Singh IJ, Tonna EA. 1974. Autoradiographic evaluation of the utilization of H3-uridine by osteoblasts of aging mice. J Gerontol 29: 1-10.
138. Sledge SL. 2001. Microfracture techniques in the treatment of osteochondral injuries. Clin Sports Med 20: 365-377.
139. Spagnoli A, O'Rear L, Chandler RL, et al. 2007. TGF-beta signaling is essential for joint morphogenesis. J Cell Biol 177: 1105-1117.
140. Stenderup K, Justesen J, Eriksen EF, et al. 2001. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 16: 1120-1129.
141. Stenderup K, Justesen J, Clausen C, Kassem M. 2003. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.
142. St-Jacques B, Hammerschmidt M, McMahon AP. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13: 2072-2086.
143. Stolzing A, Jones E, McGonagle D, Scutt A. 2008. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129: 163-173.
144. Storm EE, Kingsley DM. 1996. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122: 3969-3979.
145. Storm EE, Huynh TV, Copeland NG, et al. 1994. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368: 639-643.
146. Suva D, Garavaglia G, Menetrey J, et al. 2004. Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol 198: 110-118.
147. Takashima Y, Era T, Nakao K, et al. 2007. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129: 1377-1388.
148. Thomas JT, Lin K, Nandedkar M, et al. 1996. A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 12: 315-317.
149. Thomas JT, Kilpatrick MW, Lin K, et al. 1997. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17: 58-64.
150. Tonna EA, Pillsbury N. 1959. Mitochondrial changes associated with aging of periosteal osteoblasts. Anat Rec 134: 739-759.
151. Tonna EA, Singh IJ. 1976. An autoradiographic investigation of 3H-uridine utilization by aging mouse cartilage cells. Exp Gerontol 11: 231-234.
152. Tsuji T, Hughes FJ, McCulloch CA, Melcher AH. 1990. Effects of donor age on osteogenic cells of rat bone marrow in vitro. Mech Ageing Dev 51: 121-132.
153. Tsumaki N, Tanaka K, Arikawa-Hirasawa E, et al. 1999. Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 144: 161-173.
154. Tyndall A, Walker UA, Cope A, et al. 2007. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 9: 301.
155. Ueta C, Iwamoto M, Kanatani N, et al. 2001. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol 153: 87-100.
156. Urist MR. 1965. Bone: formation by autoinduction. Science 150: 893-899.
157. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. 1998. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthr Cartil 6: 306-317.
158. van Beuningen HM, Glansbeek HL, vander Kraan PM, van den Berg WB. 2000. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthr Cartil 8: 25-33.
159. Vortkamp A, Lee K, Lanske B, et al. 1996. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273: 613-622.
160. Wakitani S, Imoto K, Yamamoto T, et al. 2002. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 10: 199-206.
161. Walker KV, Kember NF. 1972. Cell kinetics of growth cartilage in the rat tibia. II. Measurements during ageing. Cell Tissue Kinet 5: 409-419.
162. Wilson A, Shehadeh LA, Yu H, Webster KA. 2010. Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics 11: 229.
163. Wozney JM, Rosen V, Celeste AJ, et al. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534.
164. Yoo JU, Barthel TS, Nishimura K, et al. 1998. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80: 1745-1757.
165. Zimmermann S, Voss M, Kaiser S, et al. 2003. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17: 1146-1149.
166. Zuk PA, Zhu M, Ashjian P, et al. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.